Cresset Asset Management, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Cresset Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$83.14 - $145.99 $357,917 - $628,486	-4,305 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$110.08 - $142.92 $86,632 - $112,478	-787 Reduced 15.46%	4,305 $511,000
Q4 2021 Feb 10, 2022	BUY	$99.73 - $148.48 $56,646 - $84,336	568 Added 12.56%	5,092 $702,000
Q3 2021 Nov 15, 2021	SELL	$98.85 - $138.91 $197 - $277	-2 Reduced 0.04%	4,524 $628,000
Q2 2021 Aug 10, 2021	BUY	$65.78 - $105.02 $297,720 - $475,320	4,526 New	4,526 $439,000

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $2.6B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cresset Asset Management, LLC with notifications on news.